Ozmosi | Aminolaevulinic acid Drug Profile
Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

Aminolaevulinic acid

Alternative Names: Aminolaevulinic acid
Clinical Status: Active
Latest Update: 2024-06-03
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action:

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Company Location: Asia Pacific
Company CEO:
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Aminolaevulinic acid

Countries in Clinic: China

Active Clinical Trial Count: 1

Recent & Upcoming Milestones

Highest Development Phases

Phase 2: Carcinoma in Situ|Cervical Cancer|Cervical Intraepithelial Neoplasia|Communicable Diseases|Papillomavirus Infections|Uterine Cervical Diseases|Uterine Cervical Dysplasia|Uterine Diseases

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

NCT06439433

 FDZJYX-ALA-202001

P2

Completed

Uterine Cervical Diseases|Cervical Intraepithelial Neoplasia|Uterine Cervical Dysplasia|Cervical Cancer|Papillomavirus Infections|Uterine Diseases|Communicable Diseases|Carcinoma in Situ

2023-12-20

2024-06-04

Primary Endpoints|Treatments

Recent News Events

Date

Type

Title

05/01/2024

PubMed

 Photodynamic anticancer activity evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates.

05/01/2024

PubMed

 PICO questions and DELPHI methodology for improving the management of patients with acute hepatic porphyria.

04/17/2024

PubMed

 Stability of porphyrins and porphyrin precursors in urine and plasma samples: implications for sample handling and storage.

12/13/2021

News Article

 Global Actinic Keratosis Market Insight, Epidemiology and Market Forecasts, 2018-2020 & 2021-2030 - ResearchAndMarkets.com

12/13/2021

News Article

 Global Actinic Keratosis Market Epidemiology Research Report 2021 with Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions